Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Systemic lupus erythematosus one disease or many?

(2011) N. Agmon-Levin et al.   AUTOIMMUNITY REVIEWS

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus

(2011) MU Martínez-Martínez et al.   LUPUS

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decreased live births in women with systemic lupus erythematosus

(2011) Evelyne Vinet et al.   ARTHRITIS CARE & RESEARCH

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: A prospective randomized trial

(2010) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

(2010) J. T. Merrill et al.   ARTHRITIS AND RHEUMATISM

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

(2010) B. Griffiths et al.   RHEUMATOLOGY

Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus

(2010) Katsuya Suzuki et al.   RHEUMATOLOGY INTERNATIONAL

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

(2009) Ellen M. Ginzler et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Incidence of cancer among female patients with systemic lupus erythematosus in Korea

(2009) Kwi Young Kang et al.   CLINICAL RHEUMATOLOGY

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study

(2009) C Nannini et al.   LUPUS

Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years

(2009) JD Posalski et al.   LUPUS

Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice

(2009) H. Ogawa et al.   LUPUS

Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII)

(2009) LA González et al.   LUPUS

Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study

(2009) Yoshie Kusunoki et al.   Modern Rheumatology

Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII)

(2008) L A Gonzalez et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

(2008) R Kaiser et al.   ANNALS OF THE RHEUMATIC DISEASES

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial

(2008) Paul R. Fortin et al.   ARTHRITIS AND RHEUMATISM

Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)

(2007) R M Andrade et al.   ANNALS OF THE RHEUMATIC DISEASES